1. Home
  2. ARW vs RYTM Comparison

ARW vs RYTM Comparison

Compare ARW & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arrow Electronics Inc.

ARW

Arrow Electronics Inc.

N/A

Current Price

$141.72

Market Cap

7.1B

Sector

Technology

ML Signal

N/A

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

N/A

Current Price

$88.98

Market Cap

6.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ARW
RYTM
Founded
1935
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
6.4B
IPO Year
1994
2017

Fundamental Metrics

Financial Performance
Metric
ARW
RYTM
Price
$141.72
$88.98
Analyst Decision
Sell
Strong Buy
Analyst Count
3
14
Target Price
$124.33
$129.43
AVG Volume (30 Days)
487.3K
715.6K
Earning Date
01-01-0001
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
49.93
28.34
EPS
10.93
N/A
Revenue
$30,852,935,000.00
N/A
Revenue This Year
$13.16
$57.46
Revenue Next Year
$4.51
$85.60
P/E Ratio
$12.81
N/A
Revenue Growth
10.49
N/A
52 Week Low
$86.50
$45.91
52 Week High
$162.61
$122.20

Technical Indicators

Market Signals
Indicator
ARW
RYTM
Relative Strength Index (RSI) 46.69 37.76
Support Level $120.69 $85.59
Resistance Level $161.62 $96.92
Average True Range (ATR) 4.57 4.86
MACD -2.72 -0.40
Stochastic Oscillator 30.17 11.15

Price Performance

Historical Comparison
ARW
RYTM

About ARW Arrow Electronics Inc.

Arrow Electronics Inc. is a provider of products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions. It has one of the world's broadest portfolios of product offerings available from electronic components and enterprise computing solutions suppliers, coupled with a range of services, solutions, and software, the company helps industrial and commercial customers introduce products, reduce their time to market, and enhance their overall competitiveness. The company has two business segments, the global components business and the global enterprise computing solutions.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

Share on Social Networks: